MEET QPS AT THE WORLDSymposium™ 2024; February 4 - 9, SAN DIEGO, CALIFORNIA, USA

Newsletter

Newsletter

Search Strategy Analysis Details Morris Water Maze Readouts
QPS Neuropharmacology
We now offer advanced search strategy analysis of data gathered during Morris Water Maze (MWM) test without changes to the established protocol. The MWM has been a widely recognized method to analyze spatial navigation and learning for several decades. This makes it a valuable tool for the evaluation of cognitively impaired rodent models, used to …
Read More
Tau Phosphorylation Status of PS19 Mice as Model of Tauopathies
QPS Neuropharmacology
Newest results of our R&D team show highly increased total and phosphorylated tau (ptau) levels in transgenic PS19 mice already at early age. This rodent model for tauopathies expresses the T34 isoform and 4 microtubule binding repeats (1N4R) of the tau protein with P301S mutation under the regulatory control of the murine prion promoter (Prnp). …
Read More
Repeated electromyographic measurements for longitudinal evaluation of muscle impairments
QPS Neuropharmacology
We are now able to offer longitudinal, repeated in vivo electromyographic measurements in rodent models with motor impairment. These analyses provide sensitive longitudinal readouts about your drug candidates that are unaffected by the environmental or emotional status of your animals. Typical readouts are the Compound Muscle Action Potential (CMAP), Motor Unit Action Potential (MUAP) and …
Read More
Translational read-out for preclinical Gaucher disease studies: Assessment of glucosylceramidase-β (GCase) activity in dried blood spots
QPS Neuropharmacology
Reduced GCase activity is a key causative hallmark of Gaucher disease. Monitoring changes in GCase activity at multiple time points from small volumes of whole blood, sampled as dried blood spots (DBS), can give valuable new insights on drug effects. Mutations in the human glucosylceramidase-β (GBA) gene and associated GCase activity are causative for Gaucher …
Read More
Repeated MPTP injections to model the Parkinson’s disease phenotype
QPS Neuropharmacology
Repeated MPTP injections into the mouse’ intraperitoneal space result in a Parkinson´s disease brain pathology shown as degeneration of dopaminergic neurons and neuroinflammation. Upon entering the brain, methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidizes into the highly neurotoxic compound 1-methyl-4-phenylpyridinium (MPP+) which is selectively taken up by dopaminergic neurons. Inside neurons, MPP+ disrupts mitochondrial function and causes oxidative stress, …
Read More
12312 Next

In Vitro Services

QPS Neuropharmacology provides research services with numerous standardized cell culture systems including transgenic and non-transgenic cell lines, glial cells, primary chicken and rat peripheral and central nervous system neurons of different developmental stages and organotypic brain slices. New models are developed and validated on request.
LEARN MORE

In Vivo Services

As a leading CRO for CNS drug development, QPS Neuropharmacology is the premier provider for services with transgenic animals. We have more than 20 years of experience in generating, characterizing, and maintaining transgenic disease models and applying them for drug testing projects.
LEARN MORE

Ex Vivo Services

QPS Neuropharmacology's expertise lies within the field of neurodegenerative diseases. We provide a state of the art research environment (AAALAC certified) for testing and evaluating new potential treatment approaches.
LEARN MORE

Biobank

QPS Neuropharmacology's well characterized and validated in vivo models are useful tools to push your CNS drug discovery research forward. We are happy to support your research activities with sample material from our biobank composed of various specimen derived from our in-house in vivo models.
LEARN MORE

animal models

QPS Neuropharmacology is highly experienced in generating, characterizing, and maintaining transgenic disease models and using them for drug testing projects for more than 20 years.
LEARN MORE

behavioral testing

QPS Neuropharmacology provides a wide range of behavioral tests for various indications. Most tests are evaluated using rater-independent digital animal tracking systems.
LEARN MORE

histology services

QPS Neuropharmacology offers a full set of histology services ranging from collection of tissue samples to delivering study reports that contain all experimental procedures and their outcome.
LEARN MORE

biomarkers

QPS Neuropharmacology Department of Translational Medicine offers a selection of molecular biological methods for the investigation of various diseases. The unit supports in vitro and in vivo studies performed at QPS Austria.
LEARN MORE